| Literature DB >> 20180723 |
Otto Robertsson1, Svetlana Bizjajeva, Anne Marie Fenstad, Ove Furnes, Lars Lidgren, Frank Mehnert, Anders Odgaard, Alma Becic Pedersen, Leif Ivar Havelin.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2010 PMID: 20180723 PMCID: PMC2856209 DOI: 10.3109/17453671003685442
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Characteristics of knee arthroplasty patients and operative methods as registered in the NARA database, for the period 1997–2007
| Denmark | Norway | Sweden | |
|---|---|---|---|
| No. of knee arthroplasties | 38,411 | 26,451 | 86,952 |
| No. of hospitals | 52 | 82 | 99 |
| % females | 64 | 68 | 62 |
| % OA | 82 | 85 | 92 |
| % RA | 4.3 | 5.9 | 4.7 |
| % Other | 14 | 9 | 3.4 |
| TKA | 35,569 | 23.096 | 76.304 |
| % females | 64 | 70 | 63 |
| Mean age at TKA | 69 | 70 | 71 |
| Femur & tibia cemented | 78 | 86 | 98 |
| Femur & tibia uncemented | 7.7 | 1.8 | 1.2 |
| Femur & tibia hybrid | 14 | 12 | 0.4 |
| % TKA with patellar button | 76 | 11 | 14 |
| UKA | 2,481 | 3,297 | 10,157 |
| % females | 58 | 59 | 57 |
| Mean age at UKA | 63 | 65 | 66 |
| Femur & tibia cemented | 99 | 99 | 100 |
| Femur & tibia uncemented | 1.20 | 0 | |
| Femur & tibia hybrid | 0.2 | 0.5 | 0 |
| Medial UKA | 99 | 48 | 98 |
| Lateral UKA | 0.5 | 1.4 | 2.2 |
| Laterality unknown | 0 | 51 | 0 |
| Fem-Pat | 197 | 52 | 150 |
| % females | 69 | 71 | 77 |
| Mean age at femoro-patellar | 60 | 52 | 64 |
| Other or unknown type | 164 | 6 | 341 |
Numbers of arthroplasties per hospital and year during the period 1997–2007
| Denmark | Norway | Sweden | |
|---|---|---|---|
| TKA | |||
| Mean | 146 | 70 | 143 |
| Median | 132 | 53 | 105 |
| Range | 1–345 | 1–275 | 1–527 |
| UKA | |||
| Mean | 35 | 19 | 30 |
| Median | 29 | 16 | 24 |
| Range | 1–85 | 1–57 | 1–104 |
Age- and sex-specific incidence rates of primary total knee arthroplasty per 100,000 inhabitants for the period 1997–2007. Note that due to reduced coverage, the Danish numbers have been underestimated by approximately 10–15%
| Denmark | Norway | Sweden | ||||
|---|---|---|---|---|---|---|
| Age | Women | Men | Women | Men | Women | Men |
| < 45 | 3 | 2 | 2 | 1 | 2 | 1 |
| 45–54 | 47 | 29 | 32 | 22 | 44 | 27 |
| 55–64 | 169 | 119 | 145 | 85 | 193 | 137 |
| 65–74 | 328 | 227 | 332 | 170 | 450 | 326 |
| 75–84 | 374 | 232 | 349 | 186 | 460 | 323 |
| ≥ 85 | 113 | 100 | 79 | 54 | 96 | 91 |
Figure 1.Incidence of primary knee arthroplasties. The solid lines show the incidence and the dotted lines show the age-standardized incidence for the “European” standard population (Waterhouse et al. 1976). Note that due to reduced coverage, the Danish incidence was approximately10–15% higher than shown here.
Figure 2.Proportion of age groups each year for primary knee arthroplasty.
Figure 3.Incidence of arthroplasty for rheumatoid arthritis. Note that due to reduced coverage, the Danish incidence was probably 10–15% higher than shown here.
Figure 4.Proportion of implant types used for primary knee arthroplasty.
Figure 5.Proportion of fixation methods for primary TKA.
The ten most commonly used TKA models in each country during the period 1997–2007
| Denmark | Norway | Sweden | |||
|---|---|---|---|---|---|
| PFC | 12,644 | PROFIX | 7,490 | PFC | 21,793 |
| AGC | 9,774 | LCS | 7,189 | AGC | 17,647 |
| NexGen | 4,101 | AGC | 3,129 | NexGen | 11,809 |
| Maxim | 1,466 | Genesis | 2,530 | Duracon | 8,455 |
| Advance | 1,436 | NexGen | 972 | Free-Sam | 8,103 |
| AMK | 1,022 | Duracon | 626 | Kinemax | 2,205 |
| Vanguard | 672 | E-motion | 402 | Scan | 1,518 |
| Duracon | 593 | Kinemax | 168 | Profix | 950 |
| Genesis | 131 | Tricon | 199 | Triathlon | 673 |
| Kinemax | 120 | Interax | 106 | AMK | 540 |
The five most commonly used UKA models in each country during the period 1997–2007
| Denmark | Norway | Sweden | |||
|---|---|---|---|---|---|
| Oxford | 1,683 | Oxford | 2,566 | Link-Uni | 4,308 |
| Miller Galante | 66 | Miller Galante | 281 | Miller Galante | 2,664 |
| PFC Uni | 60 | Genesis | 225 | Oxford | 1,356 |
| Preservation | 48 | Preservation | 126 | Genesis | 586 |
| Repicci II | 34 | MOD III | 54 | PFC | 352 |
Figure 6.Cumulative revision rate (CRR; lines) with 95% CI (colored areas) after total knee arthroplasty performed for osteoarthritis.
Figure 7.Cumulative revision rate (CRR; lines) with 95% CI (colored areas) for osteoarthritis cases only including the 3 implant brands that were used frequently in all 3 countries.
Figure 8.Cumulative revision rate (CRR; lines) with 95% CI (colored areas) after unicompartmental knee arthroplasty performed for osteoarthritis.
Figure 9.Cumulative revision rate (CRR; lines) with 95% CI (colored areas) for the Oxford unicompartmental implant inserted for osteoarthritis.